A monoclonal antibody that binds to anthrax toxin to prevent lethal and edema factors' intracellular entry and neutralizes toxic effects.
Obiltoxaximab
Sotrovimab
Idarucizumab
Foscarnet
Tocilizumab
Atovaquone
Remdesivir
Molnupiravir